US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist
  • 3.990
  • -0.180-4.32%
Close Nov 18 16:00 ET
  • 4.090
  • +0.100+2.51%
Pre 08:10 ET
418.56MMarket Cap-2078P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
10.66%59.88M
20.17%65.39M
13.46%51.94M
76.55%234.04M
59.73%79.74M
86.50%54.11M
91.81%54.41M
81.20%45.77M
70.40%132.57M
92.37%49.92M
Operating revenue
10.66%59.88M
20.17%65.39M
13.46%51.94M
76.55%234.04M
59.73%79.74M
86.50%54.11M
91.81%54.41M
81.20%45.77M
70.40%132.57M
92.37%49.92M
Cost of revenue
4.83%17.63M
0.16%17.64M
19.41%14.91M
43.93%74.36M
16.73%27.45M
56.68%16.82M
84.89%17.61M
58.20%12.49M
120.70%51.67M
198.38%23.52M
Gross profit
13.29%42.25M
29.75%47.75M
11.23%37.03M
97.38%159.68M
98.03%52.29M
104.01%37.29M
95.31%36.81M
91.66%33.29M
48.74%80.9M
46.14%26.41M
Operating expense
-0.47%74.5M
-11.68%82.27M
4.82%83.85M
8.20%382.01M
32.65%134.01M
-21.84%74.85M
21.47%93.15M
0.51%80M
7.29%353.07M
26.80%101.03M
Selling and administrative expenses
-4.51%62.22M
-11.43%65.34M
11.30%68.91M
33.02%292.24M
45.71%93.53M
0.65%65.16M
57.53%73.77M
40.92%61.92M
10.50%219.7M
30.20%64.19M
-Selling and marketing expense
----
104.78%123K
----
38.41%253.42M
----
----
---2.57M
----
--183.1M
----
-General and administrative expense
-4.51%62.22M
-14.57%65.22M
----
6.06%38.81M
-34.46%-159.89M
0.65%65.16M
63.03%76.34M
----
--36.6M
---118.91M
Research and development costs
30.97%11.38M
-9.77%15.9M
-17.90%14.39M
-21.60%79.41M
82.01%35.57M
-66.72%8.69M
-29.26%17.62M
-42.95%17.53M
-12.88%101.29M
-33.69%19.54M
Depreciation amortization depletion
-10.13%905K
-41.49%1.03M
0.00%545K
-67.70%10.36M
-71.60%4.91M
-79.54%1.01M
-64.47%1.76M
-88.92%545K
129.38%32.09M
1,809.27%17.3M
-Depreciation and amortization
-10.13%905K
-41.49%1.03M
0.00%545K
-67.70%10.36M
-71.60%4.91M
-79.54%1.01M
-64.47%1.76M
-88.92%545K
129.38%32.09M
1,809.27%17.3M
Operating profit
14.13%-32.26M
38.74%-34.52M
-0.25%-46.83M
18.31%-222.34M
-9.51%-81.72M
51.52%-37.56M
2.58%-56.35M
24.93%-46.71M
0.91%-272.17M
-21.13%-74.62M
Net non-operating interest income expense
-201.54%-4.1M
-104.92%-2.5M
-48.00%-2.26M
47.59%-6.07M
-172.40%-1.96M
76.36%-1.36M
62.52%-1.22M
17.68%-1.53M
-95.13%-11.58M
52.00%-721K
Non-operating interest income
-29.52%2.63M
0.98%3.18M
0.88%3M
171.62%13.29M
13.30%3.43M
220.43%3.73M
408.56%3.15M
3,807.89%2.97M
1,351.34%4.89M
4,169.01%3.03M
Non-operating interest expense
32.18%6.73M
30.01%5.68M
16.88%5.26M
17.49%19.36M
43.87%5.4M
-26.37%5.09M
12.75%4.37M
132.88%4.5M
162.62%16.47M
138.53%3.75M
Other net income (expense)
-15.70%-258K
24.37%-453K
-87.18%-438K
-32.39%-95.28M
-33.44%-94.22M
70.54%-223K
-77.22%-599K
12.03%-234K
-10,210.89%-71.97M
-882,712.50%-70.61M
Special income (charges)
----
----
----
-35.33%-94.44M
----
----
----
----
---69.79M
---69.79M
-Less：Restructuring and merger&acquisition
----
----
----
--1.26M
----
----
----
----
--0
--0
-Less:Impairment of capital assets
----
----
----
33.52%93.18M
----
----
----
----
--69.79M
--69.79M
Other non- operating income (expenses)
-15.70%-258K
24.37%-453K
-87.18%-438K
61.58%-838K
126.59%218K
70.54%-223K
-77.22%-599K
12.03%-234K
-212.46%-2.18M
-811.11%-820K
Income before tax
6.46%-36.62M
35.58%-37.47M
-2.17%-49.53M
9.01%-323.69M
-21.89%-177.9M
53.39%-39.15M
5.32%-58.17M
24.67%-48.47M
-26.45%-355.72M
-131.31%-145.95M
Income tax
400.00%1.5M
101.56%1K
-57.14%300K
0
-57.14%300K
-119.57%-64K
700K
0
Net income
73.00%-38.12M
44.28%-37.47M
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
Net income continuous Operations
3.37%-38.12M
35.51%-37.47M
-2.17%-49.53M
9.10%-323.99M
-21.89%-177.9M
53.43%-39.45M
5.93%-58.1M
24.67%-48.47M
-26.70%-356.42M
-131.31%-145.95M
Net income discontinuous operations
--0
99.96%-4K
67.97%-3.63M
----
----
---101.73M
---9.15M
---11.32M
----
----
Minority interest income
Net income attributable to the parent company
73.00%-38.12M
44.28%-37.47M
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
73.00%-38.12M
44.28%-37.47M
11.11%-53.15M
9.10%-323.99M
61.84%-55.7M
-66.69%-141.18M
-8.89%-67.25M
7.07%-59.79M
-26.70%-356.42M
-131.31%-145.95M
Basic earnings per share
77.30%-0.37
55.00%-0.36
21.62%-0.58
21.84%-3.83
65.38%-0.63
-39.32%-1.63
9.09%-0.8
21.28%-0.74
-17.51%-4.9
-95.70%-1.82
Diluted earnings per share
77.30%-0.37
55.00%-0.36
21.62%-0.58
21.84%-3.83
65.38%-0.63
-39.32%-1.63
9.09%-0.8
21.28%-0.74
-17.51%-4.9
-95.70%-1.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 10.66%59.88M20.17%65.39M13.46%51.94M76.55%234.04M59.73%79.74M86.50%54.11M91.81%54.41M81.20%45.77M70.40%132.57M92.37%49.92M
Operating revenue 10.66%59.88M20.17%65.39M13.46%51.94M76.55%234.04M59.73%79.74M86.50%54.11M91.81%54.41M81.20%45.77M70.40%132.57M92.37%49.92M
Cost of revenue 4.83%17.63M0.16%17.64M19.41%14.91M43.93%74.36M16.73%27.45M56.68%16.82M84.89%17.61M58.20%12.49M120.70%51.67M198.38%23.52M
Gross profit 13.29%42.25M29.75%47.75M11.23%37.03M97.38%159.68M98.03%52.29M104.01%37.29M95.31%36.81M91.66%33.29M48.74%80.9M46.14%26.41M
Operating expense -0.47%74.5M-11.68%82.27M4.82%83.85M8.20%382.01M32.65%134.01M-21.84%74.85M21.47%93.15M0.51%80M7.29%353.07M26.80%101.03M
Selling and administrative expenses -4.51%62.22M-11.43%65.34M11.30%68.91M33.02%292.24M45.71%93.53M0.65%65.16M57.53%73.77M40.92%61.92M10.50%219.7M30.20%64.19M
-Selling and marketing expense ----104.78%123K----38.41%253.42M-----------2.57M------183.1M----
-General and administrative expense -4.51%62.22M-14.57%65.22M----6.06%38.81M-34.46%-159.89M0.65%65.16M63.03%76.34M------36.6M---118.91M
Research and development costs 30.97%11.38M-9.77%15.9M-17.90%14.39M-21.60%79.41M82.01%35.57M-66.72%8.69M-29.26%17.62M-42.95%17.53M-12.88%101.29M-33.69%19.54M
Depreciation amortization depletion -10.13%905K-41.49%1.03M0.00%545K-67.70%10.36M-71.60%4.91M-79.54%1.01M-64.47%1.76M-88.92%545K129.38%32.09M1,809.27%17.3M
-Depreciation and amortization -10.13%905K-41.49%1.03M0.00%545K-67.70%10.36M-71.60%4.91M-79.54%1.01M-64.47%1.76M-88.92%545K129.38%32.09M1,809.27%17.3M
Operating profit 14.13%-32.26M38.74%-34.52M-0.25%-46.83M18.31%-222.34M-9.51%-81.72M51.52%-37.56M2.58%-56.35M24.93%-46.71M0.91%-272.17M-21.13%-74.62M
Net non-operating interest income expense -201.54%-4.1M-104.92%-2.5M-48.00%-2.26M47.59%-6.07M-172.40%-1.96M76.36%-1.36M62.52%-1.22M17.68%-1.53M-95.13%-11.58M52.00%-721K
Non-operating interest income -29.52%2.63M0.98%3.18M0.88%3M171.62%13.29M13.30%3.43M220.43%3.73M408.56%3.15M3,807.89%2.97M1,351.34%4.89M4,169.01%3.03M
Non-operating interest expense 32.18%6.73M30.01%5.68M16.88%5.26M17.49%19.36M43.87%5.4M-26.37%5.09M12.75%4.37M132.88%4.5M162.62%16.47M138.53%3.75M
Other net income (expense) -15.70%-258K24.37%-453K-87.18%-438K-32.39%-95.28M-33.44%-94.22M70.54%-223K-77.22%-599K12.03%-234K-10,210.89%-71.97M-882,712.50%-70.61M
Special income (charges) -------------35.33%-94.44M-------------------69.79M---69.79M
-Less：Restructuring and merger&acquisition --------------1.26M------------------0--0
-Less:Impairment of capital assets ------------33.52%93.18M------------------69.79M--69.79M
Other non- operating income (expenses) -15.70%-258K24.37%-453K-87.18%-438K61.58%-838K126.59%218K70.54%-223K-77.22%-599K12.03%-234K-212.46%-2.18M-811.11%-820K
Income before tax 6.46%-36.62M35.58%-37.47M-2.17%-49.53M9.01%-323.69M-21.89%-177.9M53.39%-39.15M5.32%-58.17M24.67%-48.47M-26.45%-355.72M-131.31%-145.95M
Income tax 400.00%1.5M101.56%1K-57.14%300K0-57.14%300K-119.57%-64K700K0
Net income 73.00%-38.12M44.28%-37.47M11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M
Net income continuous Operations 3.37%-38.12M35.51%-37.47M-2.17%-49.53M9.10%-323.99M-21.89%-177.9M53.43%-39.45M5.93%-58.1M24.67%-48.47M-26.70%-356.42M-131.31%-145.95M
Net income discontinuous operations --099.96%-4K67.97%-3.63M-----------101.73M---9.15M---11.32M--------
Minority interest income
Net income attributable to the parent company 73.00%-38.12M44.28%-37.47M11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 73.00%-38.12M44.28%-37.47M11.11%-53.15M9.10%-323.99M61.84%-55.7M-66.69%-141.18M-8.89%-67.25M7.07%-59.79M-26.70%-356.42M-131.31%-145.95M
Basic earnings per share 77.30%-0.3755.00%-0.3621.62%-0.5821.84%-3.8365.38%-0.63-39.32%-1.639.09%-0.821.28%-0.74-17.51%-4.9-95.70%-1.82
Diluted earnings per share 77.30%-0.3755.00%-0.3621.62%-0.5821.84%-3.8365.38%-0.63-39.32%-1.639.09%-0.821.28%-0.74-17.51%-4.9-95.70%-1.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data